Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17021.85 236.20 NIFTY 5052.45 63.45
 

Aurobindo Pharma Quarterly Results, Aurobindo Pharma Financial Statement & Accounts

Aurobindo Pharma

BSE: 524804  |  NSE: AUROPHARMA  |  ISIN: INE406A01029  |  Pharmaceuticals

Notes To The Accounts
Print/Copy to Excel :
« Previous Years  

Quarterly Results of Aurobindo Pharma

------------------- in Rs. Cr. -------------------
Sep '08 Dec '08 Mar '09 Jun '09 Sep '09
Sales Turnover 635.71 676.78 786.55 762.97 826.31
Other Income 0.96 48.21 0.98 29.40 10.89
Total Income 636.67 724.99 787.53 792.37 837.20
Total Expenses 627.35 637.72 628.24 593.90 619.63
Operating Profit 8.36 39.06 158.31 169.07 206.68
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- 5.54
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 9.32 87.27 159.29 198.47 217.57
Interest 10.14 17.61 48.36 17.81 13.44
PBDT -0.82 69.66 110.93 180.66 209.67
Depreciation 20.49 21.04 21.33 21.50 23.96
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT -21.31 48.62 89.60 159.16 185.71
Tax 22.65 7.75 -0.78 33.05 57.42
Net Profit -43.96 40.87 90.38 126.11 128.29
Prior Years Income/Expenses 5.46 -0.15 -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share -- 7.60 16.81 23.46 23.86
Book Value -- -- -- -- --
Equity 26.88 26.88 26.88 26.88 26.88
Reserves -- -- -- -- --
Face Value 5.00 5.00 5.00 5.00 5.00
Source : Religare Technova
Explore Aurobindo Pharm connections